Why Is Psyence Biomedical Stock Trading Lower On Tuesday?

Benzinga·04/21/2026 16:54:35

Listen to the news

Psyence Biomedical Ltd (NASDAQ:PBM) shares are trading lower on Tuesday by more than 12%, a sharp reversal after a massive rally on Monday. Investors appear to be engaging in profit-taking after the stock’s recent vertical climb.

The stock surged nearly 72.63% during Monday’s regular trading hours. At the time, the psychedelic sector received a major boost.

President Donald Trump signed an executive order to accelerate mental illness treatments. This order specifically targets faster reviews for psychedelic drugs. It also includes a reported $50 million commitment for ibogaine research.

Ibogaine Supply Chain Advantages

Psyence Biomedical stands out due to its GMP-compliant ibogaine platform. Through PsyLabs, the company manages sourcing, extraction, and purification in Africa. Psyence is pitching itself as a rare picks-and-shovels supplier. The company already holds stabilized, pharmaceutical-grade ibogaine doses in its current inventory.

Psyence Technical Analysis

PBM is rebounding from its February low but remains well below its 52-week high. The stock is trading 224.7% above its 20-day simple moving average (SMA) and 130.7% above its 100-day SMA.

The relative strength index (RSI), a momentum gauge, is 96.18.

On a longer lens, the stock is down 43.93% over the past 12 months, which keeps the bigger-picture tape fragile despite the recent surge.

Key Resistance: $12.50
Key Support: $10

PBM Stock Price Activity: Psyence Biomedical shares were down 3.54% at $10.90 during premarket trading on Tuesday, according to Benzinga Pro data.

Photo Courtesy: solarseven on Shutterstock.com

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English